<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">As of July 2020, we collected 1705 documents and informational materials related to the policy environment affecting the development and management of COVID-19 medical products based on the aforementioned methodology. 
 <xref rid="fig1" ref-type="fig">Fig. 1</xref> presents an overview of the distribution of documents by month, which demonstrates a rapid increase in documents and information released by authorities and bodies in the March–April timeframe, followed by a gradual decline in new documents and information released from May onward. This finding shows the trend of COVID-19–management efforts across the world—more information was required at the onset of the pandemic, and subsequently less information was required in the later months as various approaches to better managing the situation were adopted.
</p>
